What is the latest price of gosatuzumab/Tudavi in u200bu200b2025?

Gosatuzumab/Trodelvy (Trodelvy) is an antibody drug targeting specific types of cancer. It is mainly used to treat triple-negative breast cancer and urothelial cancer. This drug belongs to the category of antibody-drug conjugates (ADCs), whose mechanism is to achieve targeted therapy by combining antibodies with cytotoxic drugs. Gosatuzumab can selectively recognize specific antigens on the surface of cancer cells and release cytotoxic drugs directly into the interior of cancer cells, thereby effectively inhibiting tumor growth.

In China, the original drug of gosatuzumab is already on the market, but it is not yet covered by medical insurance, which results in its relatively high price. The common drug specifications are 150mg per bottle, and the price is about 10,000 yuan. Due to the lack of medical insurance support, patients have a heavy financial burden, which to a certain extent limits the widespread use of this drug. Therefore, many patients and their families are still actively seeking other affordable treatment options for this problem.

Gosatuzumab is also sold in overseas markets, including Europe, the United States and Singapore. Its drug specification is 100mg. The price is usually between RMB 10,000 and RMB 35,000. The specific price will be affected by exchange rate fluctuations. Despite the large price differences, the pharmaceutical ingredients of gosatuzumab are basically the same whether at home or abroad, which means that its efficacy and safety are similar in different markets.

Up to now, there are no generic drugs of gosatuzumab on the domestic and foreign markets, which makes patients face certain limitations in drug selection. The lack of generics also means patients have fewer economic options when receiving gosatuzumab, which may have an impact on treatment decisions for some patients.

Reference materials:https://www.trodelvy.com/